Specifically, the relative abundance of potentially pathogenic bacterial phyla—such as Proteobacteria and Fusobacteria—increases, while the abundance of beneficial bacterial phyla that produce SCFAs and exert anti-inflammatory effects (e.g., Firmicutes and Actinobacteria) shows a decreasing trend.
← all excerpts
The Dynamic Gut Microbiota: Monitoring Alterations During Lung Cancer Progression for Diagnosis and Precision Medicine.
1
—
—